JP2022132411A5 - - Google Patents

Download PDF

Info

Publication number
JP2022132411A5
JP2022132411A5 JP2022112389A JP2022112389A JP2022132411A5 JP 2022132411 A5 JP2022132411 A5 JP 2022132411A5 JP 2022112389 A JP2022112389 A JP 2022112389A JP 2022112389 A JP2022112389 A JP 2022112389A JP 2022132411 A5 JP2022132411 A5 JP 2022132411A5
Authority
JP
Japan
Prior art keywords
salt
quinolin
thiophen
piperazin
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022112389A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022132411A (ja
Filing date
Publication date
Priority claimed from PCT/JP2019/031895 external-priority patent/WO2021029020A1/ja
Application filed filed Critical
Publication of JP2022132411A publication Critical patent/JP2022132411A/ja
Publication of JP2022132411A5 publication Critical patent/JP2022132411A5/ja
Priority to JP2025027501A priority Critical patent/JP2025074104A/ja
Pending legal-status Critical Current

Links

JP2022112389A 2019-08-13 2022-07-13 経口医薬組成物 Pending JP2022132411A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025027501A JP2025074104A (ja) 2019-08-13 2025-02-25 経口医薬組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/JP2019/031895 WO2021029020A1 (ja) 2019-08-13 2019-08-13 経口医薬組成物
JPPCT/JP2019/031895 2019-08-13
PCT/JP2020/030776 WO2021029429A1 (ja) 2019-08-13 2020-08-13 経口医薬組成物
JP2021539311A JP7110495B2 (ja) 2019-08-13 2020-08-13 経口医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021539311A Division JP7110495B2 (ja) 2019-08-13 2020-08-13 経口医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025027501A Division JP2025074104A (ja) 2019-08-13 2025-02-25 経口医薬組成物

Publications (2)

Publication Number Publication Date
JP2022132411A JP2022132411A (ja) 2022-09-08
JP2022132411A5 true JP2022132411A5 (https=) 2023-08-21

Family

ID=74569440

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2021539751A Withdrawn JPWO2021029020A1 (https=) 2019-08-13 2019-08-13
JP2021539311A Active JP7110495B2 (ja) 2019-08-13 2020-08-13 経口医薬組成物
JP2021539312A Active JP7148733B2 (ja) 2019-08-13 2020-08-13 複素環化合物を含有する経口医薬組成物
JP2022112389A Pending JP2022132411A (ja) 2019-08-13 2022-07-13 経口医薬組成物
JP2022150733A Active JP7635187B2 (ja) 2019-08-13 2022-09-21 複素環化合物を含有する経口医薬組成物
JP2025020427A Pending JP2025072595A (ja) 2019-08-13 2025-02-12 複素環化合物を含有する経口医薬組成物
JP2025027501A Pending JP2025074104A (ja) 2019-08-13 2025-02-25 経口医薬組成物

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2021539751A Withdrawn JPWO2021029020A1 (https=) 2019-08-13 2019-08-13
JP2021539311A Active JP7110495B2 (ja) 2019-08-13 2020-08-13 経口医薬組成物
JP2021539312A Active JP7148733B2 (ja) 2019-08-13 2020-08-13 複素環化合物を含有する経口医薬組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022150733A Active JP7635187B2 (ja) 2019-08-13 2022-09-21 複素環化合物を含有する経口医薬組成物
JP2025020427A Pending JP2025072595A (ja) 2019-08-13 2025-02-12 複素環化合物を含有する経口医薬組成物
JP2025027501A Pending JP2025074104A (ja) 2019-08-13 2025-02-25 経口医薬組成物

Country Status (15)

Country Link
US (4) US20220273647A1 (https=)
EP (2) EP4015001A4 (https=)
JP (7) JPWO2021029020A1 (https=)
KR (2) KR20220046625A (https=)
CN (2) CN114222562A (https=)
AU (2) AU2020328351B2 (https=)
BR (2) BR112022002433A2 (https=)
CA (2) CA3150751A1 (https=)
IL (2) IL290469B2 (https=)
MX (3) MX2022001758A (https=)
MY (2) MY208261A (https=)
PH (2) PH12022550347A1 (https=)
TW (2) TWI870441B (https=)
WO (3) WO2021029020A1 (https=)
ZA (2) ZA202202319B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021029020A1 (ja) * 2019-08-13 2021-02-18 大塚製薬株式会社 経口医薬組成物
CN118742293A (zh) * 2022-01-31 2024-10-01 住友精化株式会社 药物控释制剂用组合物和药物控释制剂
JP2023173950A (ja) * 2022-05-27 2023-12-07 同仁医薬化工株式会社 経口液剤
AU2024247059A1 (en) * 2023-03-29 2025-10-30 Merck Sharp & Dohme (Uk) Limited Controlled release pde10a formulations

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (https=) 1960-11-29
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3865108A (en) 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4002173A (en) 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4207893A (en) 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
TWI320783B (en) * 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
JP4315393B2 (ja) 2005-04-14 2009-08-19 大塚製薬株式会社 複素環化合物
JP4540700B2 (ja) * 2006-10-13 2010-09-08 大塚製薬株式会社 医薬
JOP20120083B1 (ar) * 2011-04-05 2021-08-17 Otsuka Pharma Co Ltd توليفات تشتمل على بريكس ببرازول أو ملح منه وعقار ثاني للاستخدام في علاج اضطراب cns
JO3753B1 (ar) * 2011-10-14 2021-01-31 Otsuka Pharma Co Ltd قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه
TWI632921B (zh) * 2011-10-19 2018-08-21 大塚製藥股份有限公司 口服溶液
AR090775A1 (es) * 2012-04-23 2014-12-03 Otsuka Pharma Co Ltd Preparado inyectable
EP2911670A1 (en) * 2012-10-25 2015-09-02 Otsuka Pharmaceutical Co., Ltd. Prophylactic and/or therapeutic agent for behavioral and psychological symptoms associated with neurodegenerative disease or impulsive symptoms associated with mental disease containing brexpiprazole or salt thereof
CN106667969A (zh) * 2017-02-23 2017-05-17 佛山市弘泰药物研发有限公司 一种依匹哌唑缓释胶囊及其制备方法
JP6886654B2 (ja) 2017-04-11 2021-06-16 学校法人帝京大学 抗カンジダ活性組成物
WO2021029020A1 (ja) * 2019-08-13 2021-02-18 大塚製薬株式会社 経口医薬組成物

Similar Documents

Publication Publication Date Title
JP2022132411A5 (https=)
JP2011201907A5 (https=)
HRP20210487T1 (hr) Farmaceutski sastavi koji sadrže lokalni anestetik kao što je bupivakain za lokalnu primjenu u usta ili grlo
JP2012255026A5 (https=)
JP2006516570A5 (https=)
JP2009535352A5 (https=)
JP2018168191A5 (https=)
JP2015078230A5 (https=)
HRP20171793T1 (hr) Farmaceutske formulacije koje sadrže kristalne oblike (r)-7-kloro-n-(kinuklidin-3-il)benzo(b)tiofen-2-karboksamid hidroklorid monohidrata
JP2015523407A5 (https=)
MY181645A (en) Antibacterial quinoline derivatives
JP2007533687A (ja) 月経前の及び他の女性の性的障害の治療におけるフリバンセリンの使用
CN115315423A (zh) 取代芳基类化合物
MX2021002259A (es) Formas cristalinas de 3-(imidazo[1,2-b] piridazin-3- iletinil)-4-metil-n-(4-[(4-metilpiperazin-1-il) metil]-3-(trifluorometil)fenil) benzamida y su sal de monoclorhidrato.
JP2019536812A5 (https=)
JP2026021451A5 (https=)
JP2000159790A5 (https=)
JP2008516004A5 (https=)
EA200901146A1 (ru) Твердые лекарственные формы, содержащие алискирен и его фармацевтически приемлемые соли
JP2012508256A5 (https=)
JP2006507295A5 (https=)
JP2010500284A5 (https=)
NO20070952L (no) Formuleringer av suberoylanilidhydroksaminsyre og fremgangsmate for fremstilling av slike
JPWO2024181437A5 (https=)
WO2009084041A3 (en) Pharmaceutical compositions of dexibuprofen